High CPK-MB levels typically indicate heart muscle damage, such as from a heart attack.

Yes, certain medications can influence CPK-MB levels. It’s important to inform your healthcare provider about all medications you are taking.

No, fasting is not required for the CPK-MB test unless specified by your healthcare provider.

The frequency of testing depends on your health condition and your healthcare provider’s recommendations.

Abnormal CPK-MB levels may indicate heart muscle damage. Further evaluation and treatment will be necessary based on your test results.

Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.

EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.

Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.

EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.

Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.

The Hepatitis B Core Antibody Test detects antibodies against the core antigen of Hepatitis B virus, indicating past or current infection.

The test is used to diagnose Hepatitis B infection, assess immune response, and guide further testing.

No special preparation is needed. You can eat and drink normally. Inform your healthcare provider about any medications or recent health issues.

Results are typically available within 1 to 2 days after the test.

A positive result indicates past or current exposure to Hepatitis B virus. It may require further testing to determine the infection stage and appropriate management.